AMSA and Sunovion Partner to Inspire Next Generation of Innovators, Provide Students With Opportunity to Teach Neuroscience to Their Classmates

June 10, 2019 12:00 UTC
 
 

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- The Advanced Math & Science Academy Charter School (AMSA) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced completion of an inaugural program to help students understand Science, Technology, Engineering and Math (STEM) life science career paths within a pharmaceutical company and foster a deeper knowledge of neuroscience. Five AMSA upper school level students, four seniors and one junior, were selected as a team to participate in this collaborative project with Sunovion for their school’s Capstone Project.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190610005134/en/

The AMSA student team developed a lesson plan and laboratory experiences to teach seventh grade students at AMSA about the central and peripheral nervous systems, with the goal to enhance and complement their existing biology class curriculum. This material was developed in consultation with a cross-functional team from Sunovion.

“This important collaboration with Sunovion reinforces AMSA’s mission to empower students to succeed in the workplace in our modern, high-tech world. Sunovion’s team provided real-world experience and served as mentors to help inspire our students as they look forward to the next chapters in their academic careers and consider pursuing deeper learning in the life sciences and particularly in neuroscience,” said Ellen Linzey, Interim Executive Director, Advanced Math & Science Academy Charter School.

“Sunovion has an ongoing commitment to STEM education and we are proud to partner with AMSA to encourage the next generation of innovators to explore potential career paths and new frontiers in life sciences,” said Ken Koblan, PhD, Head of Global Translational Medicine & Early Development (TMED) and Head of Discovery Sciences, Sunovion, who served as Sunovion’s executive sponsor of the program with AMSA. “Our team enjoyed coaching and collaborating with the AMSA students and seeing results of their impressive work with their classmates to ignite further interest in the field of neuroscience.”

The students were awarded certificates on May 8, 2019 and seniors were provided with scholarships upon completion of their Capstone Project. A video of the ceremony and project can be viewed here.

About Advanced Math & Science Academy Charter School (AMSA)
Ranked as the #2 public high school in Massachusetts for the third consecutive year by U.S. News & World Report, The Advanced Math & Science Academy Charter School (AMSA) was chartered by the Massachusetts Department of Education in February 2004 and opened in September 2005. AMSA’s teaching model is centered on rigorous college-oriented education for all students. AMSA’s teaching philosophy involves starting challenging abstract learning, typically expected for high school students, early in the middle school grades. AMSA creates an atmosphere of celebration of knowledge where children of all backgrounds and abilities excel in all subjects, especially in math, science and technology, empowering them to succeed in the workplace in our modern, high-tech world. AMSA's core values are collective and individual values: Model Integrity, Pursue Your Excellence and Foster Community. Learn more about AMSA at www.amsacs.org and join AMSA on social media at www.amsacs.org/social.

About Sunovion Pharmaceuticals Inc. (Sunovion)
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the company’s web sites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca. Connect with Sunovion on Twitter, LinkedIn, Facebook and YouTube.

Contacts

Mike Finkle
Communications Manager
Advanced Math & Science Academy
508-597-2411
m.finkle@amsacs.org

Jennifer Baird
Senior Director, Corporate Communications
Sunovion Pharmaceuticals Inc.
508-787-4109
jennifer.baird@sunovion.com

 
 

Source: Sunovion Pharmaceuticals Inc.

Smart Multimedia Gallery

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20190610005134/en

Back to news